April 2019

Column

Editor's Page

Clinical Practice Guideline Adherence and Real-Time Interventions in Care

04/16/2019

Winston Wong, PharmD, Editor-in-Chief

Clinical practice guidelines (CPGs) in oncology provide a collation of evidence-based, consensus-driven clinical treatment and management best practices to assist physicians in making difficult treatment decisions...

...

04/16/2019

Journal of Clinical Pathways

Editorial

Busting the Myth of “Perverse Physician Incentives” to Prescribe High-Cost Drugs

04/16/2019

Nicolas Ferreyros, Managing Director, Community Oncology Alliance

As proposals directed at reducing the cost of prescription drugs are being discussed at the national level, the Community Oncology Alliance (COA) has taken a closer look at the assertion that oncologists who...

As...

04/16/2019

Journal of Clinical Pathways

Clinical Pathways GPS

Engaging Patients in Care Through Greater Access to Medical Records and Clinical Pathways

04/16/2019

Shay L Ashline, PhD

Kristin LaBounty Phillips, MPH

Matthew Pakizegee, PharmD, MS

Richard G Stefanacci, DO, MGH, MBA, AGSF, CMD—Column Editor

Without interoperability of medical records between health systems, patients are the best chance for the medical system to provide continuity of care when medical records from a different health system are difficult...

...

04/16/2019

Journal of Clinical Pathways

Pharma Insights

The Challenge With Today’s Value Assessments: Not Evolving With the Evidence

04/16/2019

Larry Blandford, PharmD—Column Editor

The methodologies employed within value assessments, especially by the Institute for Clinical and Economic Review (ICER), primarily measure value through quality-adjusted life-years (QALYs). While also the common...

The...

04/16/2019

Journal of Clinical Pathways

Business of Pathways

Why Threshold Target Performance-Based Metrics May Not Improve Population Health as Much as Treatment Pathways

04/16/2019

Michael Willis, PhD

Cheryl Neslusan, PhD

Silas Martin, MS

Pierre Johansen, MSc

Christian Asseburg, PhD

Duncan O’Brien, BEc

Ira Klein, MD, MBA, FACP—Column Editor

Many value-based payment agreements (VBAs) and programs incentivize physicians to provide care based on patients’ achievement of treatment targets, especially threshold-based metrics such as maintaining a...

Many...

04/16/2019

Journal of Clinical Pathways

Department

Pathways in Practice

ER+, HER2- Breast Cancer Pathways at University of Chicago Hospital and OHSU Knight Cancer Institute

04/16/2019

JCP Editors

In this series, we speak with cancer care practitioners about how pathways are being used in their practices, how they are being applied in a particular disease state, and what challenges remain for treatment...

In...

04/16/2019

Journal of Clinical Pathways

Column

Role of MRD as Prognostic Indicator, Clinical Trial Endpoint for Multiple Myeloma

04/16/2019

C Ola Landgren, MD, PhD

Journal of Clinical Pathways is pleased to present a new section called “CME Corner,” which will highlight, when available, relevant continuing medical education (CME) opportunities deemed to be of use to readers....

...

04/16/2019

Journal of Clinical Pathways

Tools and Resources

Tools for Transformation

How Clinical Pathways Can Support Cancer Center Growth, Care Quality, and Cost Containment

04/16/2019

Gordon Kuntz—Column Editor

Gordon Kuntz is a health care consultant and strategic advisor with over 30 years’ experience in a multitude of health care settings, working with payers and providers, and in technology and strategy. He began his...

Gordon...

04/16/2019

Journal of Clinical Pathways

Feature

Research Reports

Barriers to Lymphoma Clinical Practice Guideline Adherence: A Pilot Mixed-Methods Research Study

04/16/2019

Mihaela C Munteanu, EdD, MS

John M Burke, MD

Abstract: Little is published about adherence barriers to lymphoma clinical practice guidelines (CPGs). This article examines the most frequent barriers to adherence to lymphoma CPGs. An explanatory sequential...

...

04/16/2019

Journal of Clinical Pathways

Case Study

Patient-Reported Outcomes: Investing in Real-Time Intervention to Improve Care

04/16/2019

Diane Denny, DBA, MHA, FACHE, CPHQ, CPPS

Brandon Bosch, MPH

Morgan Hannaford, MA

Scott R Hartman, MS, PMP

Abstract: A geographically dispersed network of hospitals began the journey to integrate patient-reported outcome (PRO) data in the form of quality-of-life measurement into daily operations beginning in 2012, moving...

...

04/16/2019

Journal of Clinical Pathways

Current Issue

June 2024

Volume 10

Issue 3

Current Issue

Issue Archive

Special Reports

Sponsored

Special Report

Shedding Light on Non-Small Cell Lung Cancer & Its Impact on Patients

04/03/2023

This supplement aims to raise awareness about non-small cell lung cancer (NSCLC) and its impact on patients by providing comprehensive information to help improve early detection and appropriate care.

This supplement aims to raise...

04/03/2023

Journal of Clinical Pathways

Sponsored

JCP Special Report

Brukinsa® (Zanubrutinib) for Chronic Lymphocytic Leukemia

03/31/2023

In this product monograph, read an interview with Jeff P. Sharman, MD, as he discusses important BRUKINSA® trial data including efficacy, safety, dosing, administration, and other relevant data. These key findings supported the Food and Drug...

In this product monograph, read...

03/31/2023

Journal of Clinical Pathways

Sponsored

JCP Special Report

Tumor Lysis Syndrome: Early Diagnosis and Management

01/04/2023

This review summarizes the diagnosis, pathophysiology, and evidence-based guidelines for the prevention and management of tumor lysis syndrome, a common, acute, life-threatening disease primarily in patients with hematologic cancers and solid...

This review summarizes the...

01/04/2023

Journal of Clinical Pathways

Sponsored

JCP Special Report

A Tumor Lysis Syndrome Risk Assessment and Its Impact on Patients

08/09/2022

In an interview with Journal of Clinical Pathways, Nicholas Short, MD, shares objectives on the design and benefits of MD Anderson’s Tumor Lysis Syndrome clinical assessment for patient risk and impact on patient care.

In an interview with Journal of...

08/09/2022

Journal of Clinical Pathways

Updated NCCN Guidelines on B-Cell Lymphomas

Sponsored

JCP Special Report

Overview of the Updated NCCN Guidelines on B-Cell Lymphomas

06/15/2022

Robert Fee

Updated multiple times in 2022, the National Comprehensive Cancer Network (NCCN) Guidelines for B-Cell Lymphomas provide recommendations for the prevention, diagnosis, and management of malignancies.

Updated multiple times in 2022,...

06/15/2022

Journal of Clinical Pathways

Sponsored

Special Report

Expanded Indication for Zanubrutinib: Marginal Zone Lymphoma and Waldenström’s Macroglobulinemia

06/10/2022

In an interview with Journal of Clinical Pathways, Mitul Gandhi, MD, reviews the clinical impact and treatment approaches and challenges for patients with marginal zone lymphoma and Waldenström’s macroglobulinemia.

In an interview with Journal of...

06/10/2022

Journal of Clinical Pathways

JCP Special Report

Recommendations for Creating an Oncology Clinical Pathways Framework Tool Based on Payer, Provider, and Patient Priorities: Findings From the 2021 Care Pathways Working Group

05/20/2022

Winston Wong, PharmD

Gordon Kuntz

Robin T Zon, MD, FACP, FASCO

2021 Care Pathways Working Group

The Journal of Clinical Pathways convened the 2021 Care Pathways Working Group to identify and reconcile the different pathway drivers for each stakeholder now and five years into the future, creating a framework tool based on oncology care...

The Journal of Clinical Pathways...

05/20/2022

Journal of Clinical Pathways

Overview of the Updated NCCN Guidelines on Triple-Negative Breast Cancer

Sponsored

Special Report

Overview of the Updated NCCN Guidelines on Triple-Negative Breast Cancer

12/15/2021

Deborah Abrams Kaplan

NCCN released updates to its practice guidelines on treating triple-negative breast cancer, featuring updates on sacituzumab govitecan recommendations and more.

NCCN released updates to its...

12/15/2021

Journal of Clinical Pathways

Sponsored

Special Report

Navigating the Patient Journey for Unresectable Stage III Non-Small Cell Lung Cancer

09/16/2021

.ryan-test { display: none; } .body-content h3 { font-size: 18px; line-height: 18px; color: #000000; font-weight: 600px; } .related-content { display: none; } .body-content div > div:nth-of-type(3) .paragraph > h3 >...

.ryan-test { display:...

09/16/2021

Journal of Clinical Pathways

$Clinical Pathways Updates in Multiple Myeloma: New and Expected Treatments for Refractory and Resistant Multiple Myeloma$

Special Report

Clinical Pathways Updates in Multiple Myeloma: New and Expected Treatments for Refractory and Resistant Multiple Myeloma

01/14/2021

Journal of Clinical Pathways

Journal of Clinical Pathways Newsletter

Editorial Correspondence

April 2019

Column

Department

Tools and Resources

Feature

Current Issue

Special Reports

Subscribe

Volume 5

Specialties

Events

Year Round Education

HMP Global Products